Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
Article
PubMed
Google Scholar
Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–91.
Article
PubMed
Google Scholar
Yin J, Bai Z, Zhang J, Zheng Z, Yao H, Ye P, et al. Burden of colorectal cancer in China, 1990-2017: findings from the global burden of disease study 2017. Chin J Cancer Res. 2019;31(3):489–98.
Article
PubMed
PubMed Central
Google Scholar
Cross AJ, Ferrucci LM, Risch A, Graubard BI, Ward MH, Park Y, et al. A large prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanisms underlying this association. Cancer Res. 2010;70(6):2406–14.
Article
CAS
PubMed
PubMed Central
Google Scholar
Moore SC, Lee IM, Weiderpass E, Campbell PT, Sampson JN, Kitahara CM, et al. Association of Leisure-Time Physical Activity with Risk of 26 types of Cancer in 1.44 million adults. JAMA Intern Med. 2016;176(6):816–25.
Article
PubMed
PubMed Central
Google Scholar
Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M, Tracy RP, et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst. 1999;91(13):1147–54.
Article
CAS
PubMed
Google Scholar
Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, Tjønneland A, et al. Body size and risk of colon and rectal cancer in the European prospective investigation into Cancer and nutrition (EPIC). J Natl Cancer Inst. 2006;98(13):920–31.
Article
PubMed
Google Scholar
Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab. 1982;54(2):254–60.
Article
CAS
PubMed
Google Scholar
McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomark Prev. 1994;3(8):687–95.
CAS
Google Scholar
Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr. 2007;86(3):s836–42.
Article
PubMed
Google Scholar
DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Phys. 1979;237(3):E214–23.
CAS
Google Scholar
Singh B, Saxena A. Surrogate markers of insulin resistance: a review. World J Diabetes. 2010;1(2):36–47.
Article
PubMed
PubMed Central
Google Scholar
Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, Martínez-Abundis E, Ramos-Zavala MG, Hernández-González SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–51.
Article
CAS
PubMed
Google Scholar
McLaughlin T, Reaven G, Abbasi F, Lamendola C, Saad M, Waters D, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol. 2005;96(3):399–404.
Article
CAS
PubMed
Google Scholar
Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Triglyceride-glucose index (TyG index) is a predictor of incident colorectal cancer: a population-based longitudinal study. BMC Endocr Disord. 2020;20(1):113.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fritz J, Bjørge T, Nagel G, Manjer J, Engeland A, Häggström C, et al. The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers. Int J Epidemiol. 2020;49(1):193–204.
Article
PubMed
Google Scholar
Liu T, Song C, Zhang Y, Siyin ST, Zhang Q, Song M, et al. Hepatitis B virus infection and the risk of gastrointestinal cancers among Chinese population: a prospective cohort study. Int J Cancer. 2022;150(6):1018–28.
Article
CAS
PubMed
Google Scholar
Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.
Article
PubMed
Google Scholar
Gu X, Li Y, Chen S, Yang X, Liu F, Li Y, et al. Association of Lipids with Ischemic and Hemorrhagic Stroke: a prospective cohort study among 267 500 Chinese. Stroke. 2019;50(12):3376–84.
Article
PubMed
Google Scholar
Farahani H, Mahmoudi T, Asadi A, Nobakht H, Dabiri R, Hamta A. Insulin resistance and colorectal Cancer risk: the role of elevated plasma Resistin levels. J Gastrointest Cancer. 2020;51(2):478–83.
Article
CAS
PubMed
Google Scholar
Limburg PJ, Stolzenberg-Solomon RZ, Vierkant RA, Roberts K, Sellers TA, Taylor PR, et al. Insulin, glucose, insulin resistance, and incident colorectal cancer in male smokers. Clin Gastroenterol Hepatol. 2006;4(12):1514–21.
Article
CAS
PubMed
PubMed Central
Google Scholar
Xu J, Ye Y, Wu H, Duerksen-Hughes P, Zhang H, Li P, et al. Association between markers of glucose metabolism and risk of colorectal cancer. BMJ Open. 2016;6(6):e011430.
Article
PubMed
PubMed Central
Google Scholar
Ulmer H, Borena W, Rapp K, Klenk J, Strasak A, Diem G, et al. Serum triglyceride concentrations and cancer risk in a large cohort study in Austria. Br J Cancer. 2009;101(7):1202–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stocks T, Lukanova A, Bjørge T, Ulmer H, Manjer J, Almquist M, et al. Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can). Cancer. 2011;117(11):2398–407.
Article
PubMed
Google Scholar
Ahmed RL, Schmitz KH, Anderson KE, Rosamond WD, Folsom AR. The metabolic syndrome and risk of incident colorectal cancer. Cancer. 2006;107(1):28–36.
Article
PubMed
Google Scholar
Stürmer T, Buring JE, Lee IM, Gaziano JM, Glynn RJ. Metabolic abnormalities and risk for colorectal cancer in the physicians' health study. Cancer Epidemiol Biomark Prev. 2006;15(12):2391–7.
Article
Google Scholar
Shin HY, Jung KJ, Linton JA, Jee SH. Association between fasting serum glucose levels and incidence of colorectal cancer in Korean men: the Korean Cancer prevention study-II. Metabolism. 2014;63(10):1250–6.
Article
CAS
PubMed
Google Scholar
Parekh N, Lin Y, Vadiveloo M, Hayes RB, Lu-Yao GL. Metabolic dysregulation of the insulin-glucose axis and risk of obesity-related cancers in the Framingham heart study-offspring cohort (1971-2008). Cancer Epidemiol Biomark Prev. 2013;22(10):1825–36.
Article
Google Scholar
Palmqvist R, Hallmans G, Rinaldi S, Biessy C, Stenling R, Riboli E, et al. Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden. Gut. 2002;50(5):642–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen X, Liang H, Song Q, Xu X, Cao D. Insulin promotes progression of colon cancer by upregulation of ACAT1. Lipids Health Dis. 2018;17(1):122.
Article
PubMed
PubMed Central
Google Scholar
Wang X, Häring MF, Rathjen T, Lockhart SM, Sørensen D, Ussar S, et al. Insulin resistance in vascular endothelial cells promotes intestinal tumour formation. Oncogene. 2017;36(35):4987–96.
Article
CAS
PubMed
PubMed Central
Google Scholar
Friedrich N, Thuesen B, Jørgensen T, Juul A, Spielhagen C, Wallaschofksi H, et al. The association between IGF-I and insulin resistance: a general population study in Danish adults. Diabetes Care. 2012;35(4):768–73.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shiratsuchi I, Akagi Y, Kawahara A, Kinugasa T, Romeo K, Yoshida T, et al. Expression of IGF-1 and IGF-1R and their relation to clinicopathological factors in colorectal cancer. Anticancer Res. 2011;31(7):2541–5.
CAS
PubMed
Google Scholar
Aaronson SA. Growth factors and cancer. Science. 1991;254(5035):1146–53.
Article
CAS
PubMed
Google Scholar
Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell. 1999;4(4):597–609.
Article
CAS
PubMed
Google Scholar
Sarraf P, Mueller E, Smith WM, Wright HM, Kum JB, Aaltonen LA, et al. Loss-of-function mutations in PPAR gamma associated with human colon cancer. Mol Cell. 1999;3(6):799–804.
Article
CAS
PubMed
Google Scholar
Shimada T, Kojima K, Yoshiura K, Hiraishi H, Terano A. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells. Gut. 2002;50(5):658–64.
Article
CAS
PubMed
PubMed Central
Google Scholar